Lorbrexen 100 mg (lorlatinib) is an innovative oral medication used to treat non-small cell lung cancer (NSCLC) in patients with a specific gene mutation known as ALK-positive . This cutting-edge therapy is designed to slow the progression of Cancer, offering hope for patients in the advanced stages of Treatment For Lung Cancer where other treatments may have failed. With Lorbrexen,…
Olanib 50mg & 150mg (Olaparib) is a leading-edge oral medication used to treat various cancers, specifically ovarian, breast, prostate, and pancreatic cancers. This powerful drug belongs to a class of treatments known as PARP Inhibitor For Prostate Cancer (Poly ADP-Ribose Polymerase inhibitors). It is designed to stop cancer cells from repairing themselves, slowing tumour growth and enhancing survival rates.
